Procure Tumor and Initiate Melanoma Tumor-Reactive Tumor Infiltration

Saint John's Cancer Institute

Status: Terminated

Conditions: Melanoma

Study type: Observational

Funder types: Other

Identifiers

NCT02339987

TIL-PROCURE-0614

Details and patient eligibility

About

Procure Tumor and Initiate Melanoma Tumor-Reactive Tumor Infiltration Lymphocytes (TIL)

Full description

The purpose of this study is to allow the collection of tissue from subjects to be used in future research studies by scientists and to isolate tumor fighting cells for the future treatment of Melanoma.

Enrollment: 27 patients

Sex: All

Ages: 15+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. Patients must have metastatic melanoma with a resectable metastasis who are undergoing resection for palliation, therapeutic or curative purpose.
2. Patients must be > 15 years of age and must have metastatic melanoma.
3. Patients must meet standard pre-operative requirements as determined by the surgeon to be candidates for surgery.
4. Patients must be able to understand and sign the Informed Consent document.
5. Patients must be able to complete the supplemental data form

Exclusion criteria

1. women who are pregnant or breastfeeding
2. inability to give consent